Infectious disease companies develop technologies, diagnostics and therapeutics that prevent, detect and treat bacterial, viral, fungal and parasitic infections. Their work supports global health, outbreak response and disease surveillance.
This category includes companies working on:
Browse 118 UK infectious disease companies below.
T cell-based tuberculosis diagnostics and clinical laboratory testing services
Oxford Immunotec is an Abingdon-based diagnostics company developing, manufacturing, and supplying T cell-based diagnostic tests for infectious and immunological diseases. Its platform measures specific T cell immune responses to inform clinical diagnosis, with the T-SPOT.TB test for tuberculosis detection cleared by…
Rapid diagnostic platforms for infectious disease and consumer testing
Sapphiros is a privately held diagnostics portfolio company backed by KKR and Neoenta. UK operations include Biocrucible, a molecular diagnostics company developing ultra-rapid isothermal nucleic acid amplification assays, and an Extreme Volume Manufacturing capability producing lateral flow diagnostic tests at…
Multiplex PCR pathogen detection kits for infectious disease diagnostics
Genetic Signatures is a molecular diagnostics company supplying multiplex real-time PCR detection kits for infectious disease testing in hospital and pathology laboratories. Its proprietary technology simplifies genetic sequences to improve multiplex efficiency and increase resistance to pathogen mutation,…
Rapid bacterial viability detection using optical electrophysiology
Cytecom is a biotechnology company developing instruments for the rapid detection and quantification of live bacteria. The company's platform combines fluorescence microscopy with electrical stimulation to assess bacterial membrane potential, distinguishing viable from non-viable cells within minutes. The technology…
Phage-based blood test for tuberculosis and mycobacterial disease
PBD Biotech is a diagnostics company that develops phage-based blood and milk tests for detecting active mycobacterial infections, including bovine tuberculosis, Johne's disease and human tuberculosis. Its proprietary technology uses bacteriophages to selectively infect live mycobacteria, enabling rapid, accurate…
mRNA vaccine manufacturer and R&D partner
Moderna is a company developing and manufacturing mRNA-based medicines and vaccines across infectious disease, oncology and rare disease. Its UK Innovation and Technology Centre, opened at Harwell in September 2025, is the first facility in the UK capable of onshore mRNA vaccine manufacturing, with capacity for up to…
Multiplex nanophotonic blood testing platform for point-of-care diagnostics
Attomarker is a developer of point-of-care multiplex diagnostic devices using proprietary gold nanoparticle nanophotonic technology. Its platform measures up to 20 biomarkers simultaneously from a single finger-prick blood sample, delivering quantitative results within minutes. Tests are UKCA-marked and in clinical…
Clinical-stage peptide therapeutics for autoimmune and infectious disease
ImmuPharma is a clinical-stage biopharmaceutical company developing peptide-based therapeutics and precision diagnostics for autoimmune disease, infectious disease and metabolic disorders. Its lead candidate, a first-in-class immunormalizer for lupus, has completed a Phase III pivotal trial, aiming to restore normal…
Rapid light-based point-of-care diagnostics for infections and pathogens
ExGen Dx, previously Linear Diagnostics, is a University of Birmingham spin-out developing a portable, light-based diagnostic platform that detects multiple infections from a single sample without laboratory equipment. The technology combines a patented optical detection method with a room-temperature amplification…
Rapid diagnostic tests for Leptospirosis in animals and humans
Linnodee is a Northern Ireland-based manufacturer of in vitro diagnostic tests for the detection of Leptospirosis across animal and human health applications. Operating from ISO 9001 and ISO 13485-accredited facilities in Ballyclare, the company develops and manufactures ELISA, agglutination, and lateral flow-based…
Gene therapy immune regulators for infection, cancer and autoimmunity
Virothera develops gene therapies intended to regulate immune responses in persistent diseases. Its approach draws on human versions of immune-modifying proteins that viruses have evolved to influence immune cells. The company aims to use these proteins to create targeted treatments with potential advantages over some…
Molecular disease research spanning genetics, neurobiology and intracellular infections
Cambridge Institute for Medical Research is a University of Cambridge institute studying the molecular mechanisms of human disease. Researchers investigate protein folding, cellular quality control, membrane trafficking and organelle function, focusing on rare genetic disorders, neurological conditions and…
Calcium-compound bone and antibiotic-carrier devices for surgical infection management
Biocomposites is a UK-based medical device company that engineers, manufactures and markets calcium compound devices for infection management in bone and soft tissue. Its product range includes bone graft substitutes and antibiotic-carrier matrices used to deliver local antibiotic treatment during surgery, serving…
Computationally designed broadly protective vaccines against pandemic viruses
DIOSynVax is a clinical-stage biotechnology company developing broadly protective vaccines using a computational antigen design platform. The company's technology applies protein structure modelling and immune optimisation to engineer synthetic vaccine antigen payloads targeting conserved regions of viruses, enabling…
Semiconductor sequencing platform for point-of-need diagnostics
DNA Electronics is a diagnostics company developing a semiconductor-based DNA sequencing platform for rapid, direct-from-specimen genomic analysis at the point of need. Its proprietary system integrates sample preparation and next-generation sequencing on a microchip, enabling clinical identification of bloodstream…
Herpesvirus-vectored vaccines for livestock and companion animals
The Vaccine Group develops recombinant herpesvirus-vectored vaccines against infectious diseases affecting livestock and companion animals. Its modular platform is designed to generate durable immune responses in young animals, including those carrying maternally derived antibodies. Development programmes include…
AI-designed extended-expression RNA therapeutics for cardio-metabolic disease
ScionxBio, formerly Eleven Therapeutics, is a biotechnology company developing xRNA, a chemically expanded RNA modality engineered to extend protein expression from days to months. Combinatorial chemistry and deep learning are combined to design molecules with enhanced stability and reduced immune sensing, enabling…
End-to-end lateral flow immunoassay development and manufacturing
Global Access Diagnostics (GADx) is a contract developer and manufacturer of rapid lateral flow immunoassay tests for human, veterinary, and agricultural applications. Operating as a social enterprise, GADx provides end-to-end diagnostic development services from assay design and antibody development through to…
Structure-guided small-molecule therapeutics for antiviral and metabolic diseases
Halo Therapeutics is a University of Bristol spinout developing structure-guided small-molecule medicines for infectious and metabolic diseases. Its research combines cryo-electron microscopy, protein biophysics and computational chemistry to identify drug-binding pockets and design selective compounds. Its antiviral…
Non-profit partnership developing livestock health products for low-income markets
GALVmed is a non-profit public-private partnership facilitating the development and market access of vaccines, pharmaceuticals, and diagnostics for livestock diseases affecting small-scale producers in sub-Saharan Africa and South Asia. Operating as a product development partnership, it coordinates funding, regulatory…